Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY

ALNYLAM PHARMACEUTICALS, INC.

(ALNY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ALNYLAM PHARMACEUTICALS, INC.
02/11/21 Jahr 2020 Ergebnisveröffentlichung (geplant)
05/06/21 Q1 2021 Ergebnisveröffentlichung (geplant)
08/12/21 Erstes Halbjahr 2021 Ergebnisveröffentlichung (geplant)
11/10/21 Q3 2021 Ergebnisveröffentlichung (geplant)
Past events on ALNYLAM PHARMACEUTICALS, INC.
01/11/21 | 02:20pm JP Morgan Healthcare Conference
01/07/21 | 02:00pm Vutrisiran HELIOS-A Phase 3 Study Results Call
12/16/20 | 03:00pm R&D Day - Day - 2
12/15/20 | 03:00pm R&D Day - Day - 1
Upcoming sector events for ALNYLAM PHARMACEUTICALS, INC.
01/21/21 SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. : Extraordinary Shareholders Meeting
01/21/21 BIOCON LIMITED : Q3 2021 Earnings Release
01/27/21 LONZA GROUP LTD : FY 2020 Earnings Release
01/31/21 TURNING POINT THERAPEUTICS, INC. : Lung Cancer World Conference
More events
Past sector events for ALNYLAM PHARMACEUTICALS, INC.
01/20/21 | 06:00am EVOTEC SE : Unicredit & KeplerCheuvreux German Corporate Conference
01/19/21 | 04:30pm UNITED THERAPEUTICS CORPORATION : Tyvaso Study Results Call
01/19/21 AKESO, INC. : R&D Day
01/15/21 GUARDANT HEALTH, INC. : American society of clinical oncology gastrointestinal cancers symposium - abstract no : #423
Annual publications
Annual results201520162017201820192020 (e)
Sales
M $
Released
Forecast
Spread
41,1
39,5
3,9%
47,2
41,9
13%
89,9
72,2
25%
74,9
68,0
10%
220
221
-0,43%

476
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-277
-276
-0,46%
-409
-412
0,67%
-487
-461
-5,5%
-808
-736
-9,8%
-885
-857
-3,3%

-786
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-296
-280
-5,8%
-425
-423
-0,48%
-500
-484
-3,3%
-815
-824
1,1%
-939
-893
-5,2%

-836
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-290
-276
-5,2%
-410
-404
-1,5%
-491
-481
-2,1%
-761
-781
2,6%
-885
-853
-3,8%

-823
Net income
M $
Released
Forecast
Spread
-290
-277
-4,7%
-410
-410
-0,06%
-491
-479
-2,4%
-761
-780
2,3%
-886
-860
-3,1%

-829
EPS
$
Released
Forecast
Spread
-3,45
-3,28
-5,1%
-4,79
-4,79
0,07%
-5,42
-5,30
-2,3%
-7,57
-7,76
2,4%
-8,11
-7,93
-2,2%

-7,09
Announcement Date02/11/201602/08/201702/08/201802/07/201902/06/2020

Quarterly publications
Previous periodNext period
Quarterly results2019 Q32019 Q42020 Q12020 Q22020 Q32020 Q4 (e)
Sales
M $
Released
Forecast
Spread
70,1
57,1
23%
71,7
71,1
0,75%
99,5
90,5
10,0%
104
98,8
5,3%
126
119
5,7%

148
Operating income
(EBITDA)
M $
Released
Forecast
Spread




-193
-213
9,4%
-191
-145
-32%
-217
-179
-21%

-162
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-216
-240
9,9%
-298
-251
-19%
-210
-220
4,3%
-199
-204
2,3%
-225
-192
-17%

-202
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-209
-236
11%
-277
-238
-16%
-182
-214
15%
-178
-206
14%
-252
-200
-26%

-208
Net income
M $
Released
Forecast
Spread
-209
-234
11%
-276
-248
-12%
-182
-211
14%
-179
-200
10%
-253
-192
-32%

-205
EPS
$
Released
Forecast
Spread
-1,92
-2,10
8,7%
-2,47
-2,22
-11%
-1,62
-1,87
13%
-1,56
-1,79
13%
-2,18
-1,64
-33%

-1,72
Announcement Date10/31/201902/06/202005/06/202008/06/202011/05/2020

Financial data source
© 2021 S&P Global Market Intelligence
© 2021 Factset
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise